The Dutch guidelines for treatment with infliximab for Crohn's disease.
Vermeire
S
S
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D015201:Meta-Analysis as Topic; D009426:Netherlands; D017410:Practice Guidelines as Topic
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab